PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
14.27%
Positive revenue growth while 3088.T is negative. John Neff might see a notable competitive edge here.
9.27%
Gross profit growth above 1.5x 3088.T's 3.90%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
16.77%
EBIT growth 75-90% of 3088.T's 22.24%. Bill Ackman would push for cost reforms or better product mix to narrow the gap.
29.33%
Operating income growth similar to 3088.T's 27.90%. Walter Schloss would assume both share comparable operational structures.
31.60%
Net income growth 1.25-1.5x 3088.T's 22.18%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
31.60%
EPS growth 1.25-1.5x 3088.T's 22.18%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
31.60%
Diluted EPS growth 1.25-1.5x 3088.T's 22.18%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
77.86%
10Y revenue/share CAGR above 1.5x 3088.T's 51.82%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
81.50%
5Y revenue/share CAGR above 1.5x 3088.T's 17.47%. David Dodd would look for consistent product or market expansions fueling outperformance.
44.91%
3Y revenue/share CAGR above 1.5x 3088.T's 10.22%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-100.00%
Negative 10Y OCF/share CAGR while 3088.T stands at 100.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
149.69%
Below 50% of 3088.T's 2856.10%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
103.51%
5Y net income/share CAGR 1.25-1.5x 3088.T's 80.94%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
27.68%
3Y net income/share CAGR 50-75% of 3088.T's 38.99%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
198.41%
10Y equity/share CAGR above 1.5x 3088.T's 125.10%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
123.92%
5Y equity/share CAGR above 1.5x 3088.T's 44.96%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
56.55%
3Y equity/share CAGR above 1.5x 3088.T's 24.58%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
160.87%
Below 50% of 3088.T's 40454.99%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
84.62%
5Y dividend/share CAGR at 50-75% of 3088.T's 133.33%. Martin Whitman might see a lagging policy in mid-term shareholder returns.
33.33%
3Y dividend/share CAGR at 75-90% of 3088.T's 40.00%. Bill Ackman wants overhead or revenue enhancements to match competitor's dividend growth.
-48.82%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
7.60%
We show growth while 3088.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
13.64%
Asset growth above 1.5x 3088.T's 5.35%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
5.21%
BV/share growth above 1.5x 3088.T's 2.80%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
63.09%
Debt growth of 63.09% while 3088.T is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
-44.38%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.